NOVOCURE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.61 USD | -1.60% |
|
-14.56% | +11.25% |
| 09-03 | NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor | MT |
| 09-03 | Novocure Announces CEO Changes, Effective January 1, 2025 | CI |
Chart calendar NovoCure Limited
6f777eda44af1d796aabc5.NZK9D8tUCddsOOAUdqKvIxCCd_KbjgDOlZsoixSFLxI.B6KKf6EeO5oLfqkkIcCcb0HaR4LNvFmI499p6FzqbHRbo_J-oiBuviVnqQ~974db7981f05a63b2e72f99be89f2b53
Upcoming events on NovoCure Limited
Past events on NovoCure Limited
| 09/09/2024 02:00 | International Association for the Study of Lung Cancer World Conference |
| 08/09/2024 20:00 | International Association for the Study of Lung Cancer World Conference - Poster P1.098B.04 |
| 06/09/2024 | International Association for the Study of Lung Cancer World Conference - Poster EP.03F.04 |
| 06/09/2024 | International Association for the Study of Lung Cancer World Conference - Poster EP.03G.03 |
| 04/09/2024 21:30 | Wells Fargo Healthcare Conference |
| 25/07/2024 13:00 | Q2 2024 Earnings Call |
| 25/07/2024 12:00 | Q2 2024 Earnings Release |
| 05/06/2024 14:00 | Annual General Meeting |
| 03/06/2024 16:24 | American Society of Clinical Oncology Meeting - Abstract Number - #2008 |
| 02/05/2024 13:00 | Q1 2024 Earnings Call |
| 02/05/2024 12:00 | Q1 2024 Earnings Release |
| 27/03/2024 12:00 | METIS Phase 3 Results Call |
| 22/02/2024 13:00 | Q4 2023 Earnings Call |
| 22/02/2024 12:00 | Q4 2023 Earnings Release |
| 10/01/2024 15:30 | JPMorgan Healthcare Conference |
| 29/11/2023 20:30 | Piper Sandler Healthcare Conference - Fireside Chat |
| 18/11/2023 16:35 | Society for Neuro Oncology Meeting |
| 18/11/2023 04:06 | Society for Neuro Oncology Meeting |
| 18/11/2023 03:30 | Society for Neuro Oncology Meeting - Prolonged |
| 18/11/2023 03:30 | Society for Neuro Oncology Meeting |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 535 539 -0.81% | 538 537 0.15% | 509 509 -0.01% | 580 | 616 | 683 |
|
EBITDA Million USD | Released Forecast Spread | -34,1 -20,6 -65.7% | -78,9 -43,7 -80.45% | -222 -233 4.77% | -163 | -171 | -154 |
|
EBIT Million USD | Released Forecast Spread | -44,3 -28,8 -53.83% | -89,5 -77,0 -16.3% | -233 -246 5.21% | -163 | -174 | -161 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,1 -36,7 -41.76% | -81,8 -79,7 -2.67% | -192 -208 7.72% | -124 | -152 | -144 |
|
Net income Million USD | Released Forecast Spread | -58,4 -41,1 -41.81% | -92,5 -88,0 -5.13% | -207 -217 4.38% | -146 | -154 | -147 |
|
EPS USD | Released Forecast Spread | -0,56 -0,41 -37.32% | -0,88 -0,82 -6.68% | -1,95 -2,02 3.64% | -1,35 | -1,41 | -1,34 |
| Announcement Date | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | Juni | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 131 133 -1.79% | 128 127 0.75% | 122 128 -4.49% | 126 124 1.45% | 127 129 -1.12% | 134 134 -0.01% | 139 131 5.37% | 150 136 10.7% | 144 | 148 | 151 | 154 | 154 | 157 |
|
EBITDA Million USD | Released Forecast Spread | -22,0 -23,8 7.88% | -40,3 -24,4 -64.79% | -57,5 -36,2 -58.72% | -59,9 -54,6 -9.7% | -55,4 -60,5 8.34% | -49,0 -59,1 17.12% | -38,7 -59,0 34.35% | -30,7 -51,6 40.46% | -45,2 | -48,6 | -42,4 | -42,2 | -44,4 | -44,9 |
|
EBIT Million USD | Released Forecast Spread | -24,6 -25,8 4.65% | -43,0 -29,1 -47.83% | -60,2 -35,5 -69.72% | -62,7 -60,2 -4.15% | -58,2 -65,5 11.12% | -51,7 -64,6 19.94% | -41,5 -53,8 22.83% | -33,6 -50,1 32.91% | -44,2 | -46,7 | -45,4 | -45,3 | -47,5 | -48,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,4 -28,9 18.94% | -32,6 -30,5 -6.76% | -51,1 -35,5 -43.89% | -53,9 -51,0 -5.71% | -48,2 -56,8 15.1% | -38,5 -54,7 29.49% | -31,6 -41,4 23.66% | -22,7 -40,9 44.37% | -33,8 | -35,9 | -37,1 | -36,9 | -39,7 | -40,2 |
|
Net income Million USD | Released Forecast Spread | -26,6 -28,9 7.94% | -37,3 -32,8 -13.79% | -53,1 -37,9 -40.18% | -57,4 -52,2 -9.94% | -49,5 -56,0 11.65% | -47,1 -56,6 16.75% | -38,8 -45,1 14.15% | -33,4 -44,2 24.48% | -37,6 | -39,0 | -37,1 | -36,9 | -39,7 | -40,2 |
|
EPS USD | Released Forecast Spread | -0,25 -0,28 9.18% | -0,36 -0,31 -15.31% | -0,50 -0,34 -47.06% | -0,54 -0,50 -8% | -0,46 -0,53 12.38% | -0,45 -0,52 13.7% | -0,36 -0,42 14.24% | -0,31 -0,40 23.05% | -0,33 | -0,36 | -0,34 | -0,34 | -0,35 | -0,35 |
| Announcement Date | 27/10/22 | 23/02/23 | 04/05/23 | 27/07/23 | 26/10/23 | 22/02/24 | 02/05/24 | 25/07/24 | - | - | - | - | - | - |
More events
Past sector events for NovoCure Limited
| 25/08/2024 | SHENZHEN YHLO BIOTECH CO., LTD.: Q2 2024 Earnings Release (Projected) |
| 23/08/2024 | JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.: Q2 2024 Earnings Release |
| 21/08/2024 | APT MEDICAL INC.: Q2 2024 Earnings Release (Projected) |
| 21/08/2024 | SHANGHAI SANYOU MEDICAL CO., LTD: Q2 2024 Earnings Release (Projected) |
| 21/08/2024 07:00 | IMPLANTICA AG: Q2 2024 Earnings Release |
| 20/08/2024 06:00 | SKAN GROUP AG: Q2 2024 Earnings Release |
| 19/08/2024 | SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD: Q2 2024 Earnings Release (Projected) |
| 13/08/2024 | ASAHI INTECC CO., LTD.: Q4 2024 Earnings Release |
| 06/08/2024 21:05 | MASIMO CORPORATION: Q2 2024 Earnings Release |
| 05/08/2024 21:09 | SI-BONE, INC.: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NVCR Stock
- Calendar NovoCure Limited
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition